1. |
Was the study objective presented in a clear, specific, and measurable manner? |
7 |
|
2. |
Were the perspective of the analysis (societal, third-party payer, etc.) and reasons for its selection stated? |
4 |
|
3. |
Were variable estimates used in the analysis from the best available source (i.e., randomized control trial—best, expert opinion—worst)? |
8 |
|
4. |
If estimates came from a subgroup analysis, were the groups prespecified at the beginning of the study? |
1 |
|
5. |
Was uncertainty handled by (1) statistical analysis to address random events, (2) sensitivity analysis to cover a range of assumptions? |
9 |
|
6. |
Was incremental analysis performed between alternatives for resources and costs? |
6 |
|
7. |
Was the methodology for data abstraction (including the value of health states and other benefits) stated? |
5 |
|
8. |
Did the analytic horizon allow time for all relevant and important outcomes? Were benefits and costs that went beyond 1 year discounted (3–5%) and justification given for the discount rate? |
7 |
|
9. |
Was the measurement of costs appropriate and the methodology for the estimation of quantities and unit costs clearly described? |
8 |
|
10. |
Were the primary outcome measure(s) for the economic evaluation clearly stated and were the major short-term, long-term, and negative outcomes included? |
6 |
|
11. |
Were the health outcomes measures/scales valid and reliable? If previously tested valid and reliable measures were not available, was justification given for the measures/scales used? |
7 |
|
12. |
Were the economic model (including structure), study methods and analysis, and the components of the numerator and denominator displayed in a clear, transparent manner? |
8 |
|
13. |
Were the choice of economic model, main assumptions, and limitations of the study stated and justified? |
7 |
|
14. |
Did the author(s) explicitly discuss direction and magnitude of potential biases? |
6 |
|
15. |
Were the conclusions/recommendations of the study justified and based on the study results? |
8 |
|
16. |
Was there a statement disclosing the source of funding for the study? |
3 |
|
Total points |
|
|